Federal Policy
Latest
- Federal Policy
GAO Finds Part D Insurers Steer Enrollees to Owned Pharmacies
A GAO report examines four large, vertically integrated Medicare Part D plan sponsors that own pharmacy benefit managers and pharmacies, finding their owned pharmacies handled about 24% of drug utilization and 28% of pharmacy payments in 2023. Owned pharmacies were primarily mail-order, while non-owned pharmacies were primarily retail. For at least 94% of the 100 most commonly used drugs, payments and beneficiary cost sharing were lower at owned pharmacies, creating a financial incentive for enrollees to use plan-affiliated pharmacies, a practice GAO calls steering. For some high-cost brand-name drugs, however, cost sharing was up to $340 higher at owned pharmacies. Findings are based on 2023 CMS data and are not generalizable beyond the four selected sponsors or year.
- Federal Policy
White House Sends $90 Payments to Traditional Medicare Enrollees
The White House announced that more than 20 million traditional Medicare enrollees will receive one-time $90 payments in early October to help offset Part B premiums, funded through the Medicare Improvement Fund. Payments go via direct deposit or mailed check; enrollees whose premiums are already covered by Medicaid, those paying income-related adjustment amounts, Medicare Advantage enrollees, and people living outside the U.S. are not eligible. The fund, established in 2008, had never previously issued payments despite fluctuating congressional funding levels. The action follows separate $500 payments sent to over 950,000 people over claimed ACA exchange overcharges.
- Federal Policy
Senate Democrats Demand Answers on Preventive Task Force Overhaul
Sen. Angus King (I-Maine) and 16 other Senate Democrats sent a letter to HHS Secretary Robert F. Kennedy Jr. demanding answers about his recent overhaul of the U.S. Preventive Services Task Force, the expert panel that determines which preventive services insurers must cover without cost-sharing. The senators are pressing HHS on the rationale and process behind the changes to the panel's composition. No deadline for HHS response is specified in the available reporting. The task force's recommendations shape coverage mandates across commercial insurance and have downstream influence on Medicaid benefit design and quality benchmarks.

- Federal Policy
RFK Jr., Oz to Unveil Health Price Transparency Initiative
HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz are set to announce new health care price transparency efforts Monday, joined by Labor Secretary Keith Sonderling, Deputy Treasury Secretary Francis Brooke, and the FTC Chair. The announcement spans multiple federal agencies, suggesting a coordinated cross-government push rather than a single CMS rule. Details on the specific policy actions, scope, and effective dates were not available ahead of the event. The multi-agency involvement signals the initiative may touch pricing disclosure requirements across commercial, employer-sponsored, and government health coverage.

- Federal Policy
CMS Finalizes Transparency in Coverage Rule Updates
CMS has issued a fact sheet summarizing final rules under the Transparency in Coverage framework (CMS 9882-F), which govern how health plans must disclose pricing and cost-sharing information to consumers. The rules primarily apply to group health plans and health insurance issuers in the individual and group markets, requiring public disclosure of negotiated rates, out-of-network allowed amounts, and prescription drug pricing data. Affected plans must build compliance into their operations according to the applicable effective dates outlined in the rule. The requirements matter for payers and purchasers navigating price transparency obligations, though the rule is centered on commercial and group market coverage rather than Medicaid.
- Federal Policy
CMS Finalizes Rule Expanding Price Transparency, Coverage Comparison Tools
CMS announced new regulations intended to make it easier for consumers to find, compare, and report healthcare pricing and coverage information. The rule builds on existing hospital and payer price transparency requirements, aiming to improve enforcement and usability of published pricing data. Affected stakeholders include hospitals, health plans, and insurers subject to transparency mandates, as well as consumers seeking cost estimates. CMS did not specify a Medicaid-specific component in this release, though managed care plans operating across markets may face overlapping compliance obligations.
- Federal Policy
CMS Finalizes Overhauled Price Transparency Rules for Payers
CMS, along with the Labor and Treasury departments, finalized a rule overhauling price transparency requirements for health plans and self-insured employers, revising regulations first established in 2020. The rule eliminates so-called "ghost rates" for services providers rarely perform, consolidates in-network rate files by provider network rather than by plan, lowers the claims threshold for reporting out-of-network allowed amounts, and requires a named executive to attest to data accuracy. The rule takes effect Dec. 5, 2026, with most data requirements phased in through 2027, including attestation and file changes by March 2027 and taxonomy/utilization file requirements by September 2027. Regulators declined to require consumer-friendly cost summaries or a "what changed" file, citing limits on reflecting individual cost-sharing.
- Federal Policy
Report Compares Rural, Urban Health Center Patients and Funding
A research brief analyzes 2025 national data from the Uniform Data System to compare patient populations and financing between rural and urban community health centers. It examines how these centers differ in payer mix, patient demographics, and revenue sources, and considers how recent federal policy changes could affect their financial stability. The brief does not describe a specific regulatory action but synthesizes existing UDS data to project potential impacts on health center operations going forward.
- Federal Policy
Grassley Urges Trump Administration to Finalize Kratom Rule
Sen. Chuck Grassley (R-Iowa) publicly pressed the Trump administration to finalize a proposed rule restricting sale of 7-hydroxymitragynine (7OH), a concentrated kratom compound, calling the substance deadly and demanding it be pulled from gas stations, vape shops, and other retail outlets. The statement does not specify a new regulatory action by the administration, but amplifies pressure on FDA/DEA to move from proposed to final rule status. No effective date is given, as the underlying rule remains unfinalized. The push concerns a substance regulated outside typical Medicaid pharmacy channels, though it intersects with broader opioid-use and behavioral health policy concerns.

- Federal Policy
CMS Issues FAQ on Medicare Improvement Fund Premium Rebate
CMS published a frequently-asked-questions fact sheet explaining the Medicare Improvement Fund Premium Rebate. The document addresses how the rebate works and who qualifies for it under Medicare, clarifying operational and eligibility questions for beneficiaries and stakeholders. No specific effective date or dollar figures are detailed beyond the FAQ format itself. The guidance is relevant primarily to Medicare administration rather than Medicaid.
- Federal Policy
CMS Opens 60-Day Comment Period on Information Collection Request
CMS published a Federal Register notice seeking public comment on a proposed information collection activity, as required under the Paperwork Reduction Act of 1995. The notice does not specify the particular program or data collection at issue beyond the standard PRA procedural requirements. Commenters have 60 days to weigh in on the necessity, burden estimates, and clarity of the proposed collection, as well as suggestions for reducing reporting burden through automation or other means. This is a routine procedural step CMS must take before implementing or renewing any information collection requirement.
- Federal Policy
CMS Launches Portal for 340B Part D Claims Data Submissions
CMS opened its Medicare Part D Claims Data 340B Repository on Oct. 1 for voluntary submissions, ahead of a proposed Jan. 1, 2027 deadline when submissions would become mandatory for 340B covered entities and their third-party administrators. The repository collects data elements from Part D 340B claims tied to the Medicare Prescription Drug Inflation Rebate Program. The launch coincides with other Jan. 1, 2027 changes, including 15 additional drugs moving to negotiated Medicare prices, the CY 2027 Part D benefit redesign, and a planned 340B rebate pilot shifting some covered entities to a post-sale rebate model. It also arrives amid disputes between drugmakers like Eli Lilly and Johnson & Johnson, which require direct claims-data submission from covered entities, and hospital groups and states that have challenged or restricted that practice; a CMS-run repository offers an alternative compliance path.
- Federal Policy
HRSA Approves 10 Drugmakers for 340B Rebate Pilot
HRSA announced Oct. 1 that it has approved 10 manufacturers, including AbbVie, Amgen, AstraZeneca, Merck and Pfizer, to join a revised 340B Rebate Model Pilot Program covering drugs like Eliquis, Jardiance and Enbrel. Starting Jan. 1, 2027, covered entities will keep buying through existing 340B wholesaler accounts at wholesale acquisition cost but submit limited claims data within 45 days so manufacturers can pay or deny rebates within 10 days; denials cannot be based on eligibility, diversion or Medicaid duplicate-discount concerns, which must go through separate audit channels. This is a reworked version of a pilot a federal court in Maine previously vacated and remanded to HRSA. HRSA will publish periodic implementation findings with a final evaluation due by April 2028, while the AHA says it opposes the program and is weighing options to stop it.
- Federal Policy
CMS Finalizes Major Updates to Medicare TAVR Coverage Rules
CMS issued a Decision Memorandum on September 10, 2026, finalizing a reconsideration of the National Coverage Determination for Transcatheter Aortic Valve Replacement, prompted by a request from device manufacturer Edwards Lifesciences. The updated NCD relaxes the 2019 rules by allowing asynchronous heart-team patient evaluations, eliminating the requirement for two operators from different specialties, replacing hospital-level volume requirements with operator-level thresholds (20 valve procedures annually, 15 of which must be TAVR), and ending coverage-with-evidence-development requirements for symptomatic severe aortic stenosis. CMS also created a new coverage pathway for asymptomatic severe aortic stenosis, limited to CMS-approved studies. Hospitals and physicians performing TAVR must comply with the revised conditions of Medicare payment, as noncompliance can trigger False Claims Act exposure.
- Federal Policy
Analysis: Medicare Part D Plan Premiums Vary Widely for 2027
A new analysis of the 2027 Medicare Part D stand-alone prescription drug plan (PDP) market finds a modest reduction in the number of available plans alongside uneven premium changes. Many enrollees will see monthly premium increases of less than $10, but others face increases of $50 or more if they remain in their current plan rather than switching during open enrollment. The brief highlights that passive enrollees, those who don't actively shop plans each year, are most at risk of steep cost increases. This affects the millions of Medicare beneficiaries who rely on stand-alone PDPs for drug coverage, distinct from Medicare Advantage drug plans.
- Federal Policy
CDC Proposal Would Cut Disability Questions From Health Survey
CDC has proposed a major redesign of its National Health Interview Survey, set to take effect in 2028, shifting from in-person interviews to a "sequential mixed-mode" approach with shorter, simplified questionnaires. Many detailed topics fielded annually would be dropped, including a question asking whether a physician diagnosed the respondent with an intellectual or developmental disability or autism; only "foundational measures" based on the Washington Group Short Set on functional status would remain. Disability advocates, including The Arc's CEO Katy Neas, warn the change could worsen undercounting of people with disabilities and disrupt longitudinal tracking of disability prevalence, health outcomes, and funding decisions. The proposal, dated Aug. 20, is open for public comment until Oct. 19.
- Federal Policy · SD
CMS Awards $7.2 Million for South Dakota Ambulance Telemedicine
CMS announced $7.2 million in federal funding to expand ambulance-based telemedicine and upgrade emergency communications infrastructure across South Dakota. The funding will support rural emergency medical services, including equipment for real-time video consultation between ambulance crews and physicians during transport. South Dakota officials and providers will implement the upgrades, which aim to improve emergency care access in rural and underserved areas of the state. The announcement did not specify an implementation timeline or the funding mechanism involved.
- Federal Policy
HHS Picks 8 Communities for $96M Homelessness, Addiction Program
HHS Secretary Robert F. Kennedy Jr. announced in Houston that eight communities have been selected to receive funding through the new STREETS program, administered by SAMHSA. The program will distribute $96 million over four years to help selected communities build coordinated systems of care for people experiencing homelessness who have serious mental illness, substance use disorders, or co-occurring disorders. The announcement names the funding recipients but does not detail specific program start dates or application requirements for future rounds.
- Federal Policy
Explainer Chapter Covers Medicare Eligibility, Coverage, and Financing
A Health Policy 101 educational chapter provides a primer on Medicare, the federal health insurance program covering more than 68 million people age 65 and older or with long-term disabilities. It walks through eligibility rules, covered benefits, and program spending, and reviews the growing role of private Medicare Advantage plans in delivering benefits. The chapter also discusses financing challenges driven by rising health care costs and an aging population. No new policy action or data release is reported; this is background reference material rather than a report on a specific event.
- Federal Policy
CMS Opens 340B Part D Claims Data Repository for Voluntary Use
CMS launched its 340B Part D claims data repository on October 1, allowing covered entities and third-party administrators to begin submitting claims data voluntarily. CMS has proposed requiring mandatory submissions starting January 1, 2027. To support entities during the transition, CMS has published a user guide, companion guide, fact sheet, and FAQ. The repository is intended to improve tracking of 340B drug claims under Medicare Part D.